Study showed that HDCA treatment inhibited the proliferative capacity of CRC cells through the FXR/EREG/EGFR axis [14], but the role of HDCA in promoting the progression of CRC through a high-fat diet is not fully clear. The gene discussed is NR1H4; the disease is colorectal carcinoma.